William E. Richards

833 total citations · 1 hit paper
14 papers, 547 citations indexed

About

William E. Richards is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, William E. Richards has authored 14 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Obstetrics and Gynecology, 7 papers in Reproductive Medicine and 4 papers in Oncology. Recurrent topics in William E. Richards's work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers) and BRCA gene mutations in cancer (2 papers). William E. Richards is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers) and BRCA gene mutations in cancer (2 papers). William E. Richards collaborates with scholars based in United States, South Korea and China. William E. Richards's co-authors include Daniela Matei, Helen Huang, David S. Miller, David G. Mutch, Krishnansu S. Tewari, Virginia L. Filiaci, Katherine Moxley, John Nakayama, David M. O’Malley and Paul DiSilvestro and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Obstetrics and Gynecology.

In The Last Decade

William E. Richards

14 papers receiving 539 citations

Hit Papers

Adjuvant Chemotherapy plus Radiation for Locally Advanced... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
    2019 289 citations Daniela Matei, Virginia L. Filiaci et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Richards United States 8 345 330 126 79 67 14 547
Jennifer Ducie United States 13 436 1.3× 409 1.2× 81 0.6× 120 1.5× 62 0.9× 16 630
Hidetaka Nomura Japan 13 399 1.2× 314 1.0× 104 0.8× 109 1.4× 93 1.4× 78 625
Britta Nordström Sweden 9 251 0.7× 185 0.6× 63 0.5× 70 0.9× 54 0.8× 20 376
Caroline Lundgren Sweden 9 593 1.7× 501 1.5× 55 0.4× 106 1.3× 52 0.8× 18 696
M. Lapresa Italy 10 199 0.6× 294 0.9× 113 0.9× 29 0.4× 42 0.6× 16 420
Manami Imai Japan 13 359 1.0× 388 1.2× 123 1.0× 68 0.9× 26 0.4× 19 626
Lucía González‐Cortijo Spain 11 192 0.6× 179 0.5× 108 0.9× 59 0.7× 84 1.3× 26 434
Ian Harley United Kingdom 13 243 0.7× 214 0.6× 102 0.8× 159 2.0× 68 1.0× 23 506
Anne M. van Altena Netherlands 16 247 0.7× 390 1.2× 125 1.0× 30 0.4× 38 0.6× 48 594
Audrey P. Garrett United States 9 230 0.7× 269 0.8× 77 0.6× 29 0.4× 32 0.5× 15 467

Countries citing papers authored by William E. Richards

Since Specialization
Citations

This map shows the geographic impact of William E. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Richards more than expected).

Fields of papers citing papers by William E. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Richards. The network helps show where William E. Richards may publish in the future.

Co-authorship network of co-authors of William E. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Richards. A scholar is included among the top collaborators of William E. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Richards. William E. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Matei, Daniela, Mahesh Kudrimoti, Margaret M. Steinhoff, et al.. (2023). Overall survival in NRG258, a randomized phase III trial of chemo-radiation vs. chemotherapy alone for locally advanced endometrial carcinoma (LBA 5). Gynecologic Oncology. 176. S30–S31. 6 indexed citations
2.
Matulonis, Ursula A., Helen Huang, Virginia L. Filiaci, et al.. (2021). Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study. Gynecologic Oncology. 164(2). 428–436. 4 indexed citations
3.
Carter, Jeanne, Helen Huang, Jane M. Armer, et al.. (2020). GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecologic Oncology. 160(1). 244–251. 45 indexed citations
4.
Beaussant, Yvan, William E. Richards, Ira Byock, et al.. (2020). An Agenda of Psychedelic-Assisted Therapy Research in Seriously Ill Patients: Highlights from the Harvard Radcliffe Institute Exploratory Seminar (FR405). Journal of Pain and Symptom Management. 59(2). 446–447. 1 indexed citations
5.
6.
Matei, Daniela, Virginia L. Filiaci, Marcus E. Randall, et al.. (2019). Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer. New England Journal of Medicine. 380(24). 2317–2326. 289 indexed citations breakdown →
7.
8.
Rath, Kellie S., et al.. (2010). Expression of soluble interleukin-6 receptor in malignant ovarian tissue. American Journal of Obstetrics and Gynecology. 203(3). 230.e1–230.e8. 30 indexed citations
9.
Miller, Brigitte, John A. Blessing, Frederick B. Stehman, et al.. (2010). A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study. Gynecologic Oncology. 118(2). 139–144. 20 indexed citations
10.
Geest, Koen De, John A. Blessing, Robert Morris, et al.. (2009). Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 28(1). 149–153. 52 indexed citations
11.
Smith, Simon A., William E. Richards, Parviz Hanjani, et al.. (2001). BRCA1 Germline Mutations and Polymorphisms in a Clinic-Based Series of Ovarian Cancer Cases: A Gynecologic Oncology Group Study. Gynecologic Oncology. 83(3). 586–592. 22 indexed citations
12.
Richards, William E., et al.. (1999). BRCA1-Related and Sporadic Ovarian Cancer in the Same Family: Implications for Genetic Testing. Gynecologic Oncology. 75(3). 468–472. 4 indexed citations
13.
Reedy, Mark B., et al.. (1999). Ovarian Steroid Cell Tumors, Not Otherwise Specified: A Case Report and Literature Review. Gynecologic Oncology. 75(2). 293–297. 38 indexed citations
14.
Richards, William E., et al.. (1981). Ocean thermal energy conversion: technology development. 7(1-4). 327–352. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Ducie Breakdown of academic impact, for papers by Hidetaka Nomura Breakdown of academic impact, for papers by Britta Nordström Breakdown of academic impact, for papers by Caroline Lundgren Breakdown of academic impact, for papers by M. Lapresa Breakdown of academic impact, for papers by Manami Imai Breakdown of academic impact, for papers by Lucía González‐Cortijo Breakdown of academic impact, for papers by Ian Harley Breakdown of academic impact, for papers by Anne M. van Altena Breakdown of academic impact, for papers by Audrey P. Garrett
Rankless by CCL
2026